Current role
Cameron Turtle
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-06-21–present
-
BridgeBio Pharma, Inc. (BBIO)
Proxy statement
Current -
Current
-
Current
-
Start not stated–2025-12-11
-
Start not stated–2025-12-11
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | $665,000 | $6,707,361 |
| 2024 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | $625,000 | $6,960,186 |
| 2023 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | $272,850 | $15,919,545 |
| 2020 | BridgeBio Pharma, Inc. (BBIO) | Ph.D.\ Chief Strategy Officer | $400,000 | $4,561,482 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.